echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Weili Medical's exclusive agent product Class III medical device registration certificate was renewed and approved

    Weili Medical's exclusive agent product Class III medical device registration certificate was renewed and approved

    • Last Update: 2022-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 17, Weili Medical announced that the company's exclusive agency product Class III medical device registration certificate has been approved by NMPA recently


    This product is a catheter with a balloon, the catheter is made of natural latex, with gold-silver-palladium alloy coating and hydrogel coating, all coatings do not contain drug ingredients


    It is suitable for bladder urination of patients or for bladder urination and irrigation of patients after surgery, and the continuous cumulative use time does not exceed 30 days


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.